
|
Practice Areas :
Intellectual Property
:
Patent Litigation and Enforcement

Patton Boggs’ patent litigation practice comprises all phases of litigation including counseling, discovery, Markman hearings, pretrial proceedings, mediation, trial and appeals before the Court of Appeals for the Federal Circuit and the Supreme Court. Our patent litigation group incorporates technically trained patent attorneys and seasoned trial attorneys to yield proven cost-effective results. Our patent litigators also use their expertise to assist clients in trade secret misappropriation cases.
We recognize that the only reason for protecting and enforcing IP is to advance the company’s business interests and increase shareholder value. This philosophy guides and defines our patent enforcement practice. Our patent litigators begin with an evaluation of all available options prior to the initiation of litigation to ensure the strategy to be implemented meets the company’s business objectives, and protects the company’s substantive rights. Throughout the course of litigation, we strategically focus our efforts to bring about a successful resolution to the dispute—either at trial or through a negotiated settlement.
It is increasingly common for large-scale patent litigation to have multi-national components, in which litigation proceeds concurrently in both the U.S. and in one or more foreign jurisdictions. Our patent litigation lawyers have unparalleled experience in coordinating and directing litigation among multiple jurisdictions, working closely with foreign associates and attorneys in local jurisdictions to ensure that consistent and successful positions are advanced in each forum.
Representative Matters
- CEATS, Inc. v. Continental Airlines, Inc., et al., - Represented Qatar Airways in 30+ defendant patent litigation involving web-based reservation systems.
- Wordcheck Tech, Inc. v. Alt-N Technologies, Inc. – Represented Fidelis Security in 60+ defendant patent litigation involving systems and methods related to storing word checking software modules and electronic dictionaries.
- Tex-Pat, LLC v. L-3 Communications Holdings, Inc. – Represented L-3 Communications in patent false marking case.
- Cricket Communications, Inc. v. MetroPCS Communications, Inc. – Represented Royal Street Communications, LLC in wireless communications patent litigation.
- DataSci, LLC v. Quintiles Transnational Corp.; PharmaNet, Inc. v. DataSci, LLC; DataSci, LLC v. Omnicomm Systems, Inc. – Represented DataSci in patent cases involving web-based electronic data capture systems for clinical trials.
- Hesco Bastion Limited v. ACS Holdings USA, LLC – Represented Hesco in patent litigation involving rapidly deployable barrier systems for military protection/fortification.
- Pressure Products Medical Supplies, Inc. v. Greatbatch Medical, Inc. – Represented Greatbatch in medical device litigation regarding valved, peelable/splittable introducers.
- LG Philips v. NEC Corp. – Represented LG Philips in patent litigation involving TFT technology for computer monitors.
- ArrivalStar S.A. v. CES Wireless Technologies Corp. – Represented CES Wireless in patent litigation involving GPS tracking software and systems.
- ArrivalStar S.A. v. Remote Dynamics, Inc. – Represented Remote Dynamics in patent litigation involving GPS tracking software and systems.
- Patent Group, LLC v. Daisy Manufacturing Co. – Represented Daisy Manufacturing in patent false marking case.
- Channel Intelligence, Inc. v. Lemonade, Inc., et al., - Represented Channel Intelligence in patent litigation involving web-based e-commerce systems for tracking consumer preferences.
- Life Technologies, Inc. (formerly Invitrogen Corp.) v Clontech Laboratories, Inc. – Represented Clontech in patent litigation involving RNase Reverse Transcriptase products.
- Life Technologies, Inc. v. Stratagene Corp. – Represented Stratagene in patent litigation involving RNase Reverse Transcriptase products.
- Invitrogen Corp. (now Life Technologies, Inc.) v. Stratagene Corp. – Represented Stratagene in patent litigation involving competent cells.
- Stratagene Corp. v. Invitrogen Corp. – Represented Stratagene in patent litigation involving DNA polymerase compositions and uses thereof.
- Baylor College of Medicine and BCM Technologies, Inc. and Invitrogen Corp. v. Clontech Laboratories, Inc. – Represented Clontech in theft of trade secret litigation and breach of contract claims involving Clontech’s Creator™ products relating to Cre mediated recombination.
- Clontech Laboratories, Inc. v. Life Technologies, Inc. (formerly Invitrogen, Corp.) – Represented Clontech in a patent false marking case.
- Becton Dickinson & Co. v. Tyco Healthcare LP; MBO Laboratories, Inc., v. Becton Dickinson & Co – Represented Becton Dickinson in medical device litigation regarding safety needles.
- Biacore AB v. Thermo BioAnalysis, Inc. – Represented Biacore in litigation involving biosensors.
- Applera Corp. v. Bio-Rad Labs., MJ Research and Stratagene Corp. – Represented Stratagene in litigation involving Real Time qPCR machines.
- Digene Corporation v. Ventana Medical System, Inc. and Beckman Coulter, Inc. – Represented Digene in patent litigation involving antibody detection kits and systems directed to human papillomavirus (HPV).
- Enzo Biochem v. Digene Corporation – Represented Digene in patent litigation involving systems and methods for antibody detection of viruses.
- Benitec Australia, Inc. v. Nucleonics Inc. – Represented Benitec in patent litigation involving RNAi technology.
- Stratagene Corp. v. Biometra GMBH and Biometra U.S., Inc. – Represented Stratagene in patent litigation involving T Gradient thermo cyclers.
- Ajinomoto Co., Inc. v. Archer-Daniels Midland Co. – Represented Ajinomoto in patent litigation involving methods using recombinant biotechnology to produce amino specific amino acids, threonine and lysine.
- Oxford Gene Technology, Ltd. v. Mergen Ltd., Clontech Laboratories, Inc. d/b/a BD Biosciences Clontech, PerkinElmer Life Sciences, Inc. – Represented Clontech in patent litigation involving nucleic acid array products.
- Sanitec Industries, Inc. v. Micro-Waste Corp. – Represented Santiec in patent litigation involving sanitary disposal of medical waste.
- Original Creatine Patent Co., Ltd. v. MET-RX USA, Inc. – Represented OCPC in patent litigation involving nutritional supplement.
- Original Creatine Patent Co., Ltd. v. NBTY, Inc. – Represented OCPC in patent litigation involving nutritional supplement.
|
practice AREA BREAKING NEWS
|
 |
Intellectual Property Client Alert: Trademark Clearinghouse Adds to Brand Protections
April 11, 2013
|
 |
Intellectual Property Client Alert: Definiteness in Patent Claims
February 21, 2013
|
 |
INTELLECTUAL PROPERTY CLIENT ALERT: Federal Circuit Potential for Indirect Infringement Liability Provides a Justiciable Controversy for Declaratory Judgment Jurisdiction
February 8, 2013
|
 |
INTELLECTUAL PROPERTY CLIENT ALERT: Significant Provisions of the America Invents Act Set to Take Effect in March
February 6, 2013
|
 |
INTELLECTUAL PROPERTY CLIENT ALERT: Delaware Court Dismisses “Anticipatory” First-Filed Declaratory Judgment Action
January 30, 2013
|
 |
INTELLECTUAL PROPERTY CLIENT ALERT: New Patent Fees Finalized
January 25, 2013
|
 |
INTELLECTUAL PROPERTY CLIENT ALERT: A Trademark Claim Will Not Preclude a Later Patent Infringement Suit
December 6, 2012
|
 |
INTELLECTUAL PROPERY CLIENT ALERT: Federal Circuit Confirms Time-Bar on Patent Inventorship Suits
November 27, 2012
|
 |
INTELLECTUAL PROPERTY CLIENT ALERT: Federal Circuit Panel Majority Calls for En Banc Review of Proper Standard of Review for Claim Construction Rulings Made by the U.S. Patent and Trademark Office
October 26, 2012
|
 |
INTELLECTUAL PROPERTY CLIENT ALERT: Patents Subject to Disclaimer Deemed Unenforceable if Owned by Different Subsidiaries
October 9, 2012
|
|